Pages that link to "Q49901693"

The following pages link to Prolongation and enhancement of serum methotrexate concentrations by probenecid (Q49901693):

Displaying 45 items.

• OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies (Q27001267) (← links)
• Flavonoids are inhibitors of human organic anion transporter 1 (OAT1)-mediated transport (Q34125070) (← links)
• Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it (Q35953662) (← links)
• Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria (Q36028335) (← links)
• Drug interactions in the oncology patient (Q36279299) (← links)
• Recommendations for the use of methotrexate in juvenile idiopathic arthritis (Q36677248) (← links)
• Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis (Q37314370) (← links)
• Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. (Q37334707) (← links)
• Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection (Q37780903) (← links)
• Pharmacokinetic drug-drug interactions with methotrexate in oncology (Q37960131) (← links)
• Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy. (Q38024126) (← links)
• Pharmacokinetic drug interactions of commonly used anticancer drugs. (Q38164714) (← links)
• Saturable pharmacokinetics in the renal excretion of drugs (Q38618255) (← links)
• Renal Drug Transporters and Drug Interactions (Q39140289) (← links)
• Methotrexate in psoriasis: revised guidelines (Q39514650) (← links)
• Pharmacologic considerations in the treatment of acute lymphoblastic leukemia (Q39522996) (← links)
• Clinical management of cytotoxic drug overdose (Q39536333) (← links)
• High-dose Methotrexate Therapy-An Area of Uncertainty* (Q39852771) (← links)
• Problems of Antiarthritic Therapy in the Elderly (Q40170807) (← links)
• The pharmacological role of the kidney (Q40282215) (← links)
• Clinical pharmacokinetics of probenecid (Q40303270) (← links)
• Antineoplastic agents. Drug interactions of clinical significance. (Q40449518) (← links)
• Polypharmacy. Pharmacokinetic perspectives (Q40743031) (← links)
• Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam (Q41015337) (← links)
• Clinical Monitoring of Therapeutic Drugs (Q41175485) (← links)
• Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma (Q41220602) (← links)
• Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family (Q41537511) (← links)
• Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design (Q41635852) (← links)
• Pharmacokinetics of cephradine given intravenously with and without probenecid (Q42131386) (← links)
• Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen (Q42201490) (← links)
• Clinically relevant drug-drug interactions in oncology (Q42284655) (← links)
• Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicity (Q44208537) (← links)
• Pharmacokinetic interaction between methotrexate and chloral hydrate (Q44745765) (← links)
• Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences? (Q47250639) (← links)
• Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3. (Q48249474) (← links)
• Renal Transporter-Mediated Drug-Drug Interactions: Are They Clinically Relevant? (Q51659189) (← links)
• Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits. (Q52680287) (← links)
• Stereoselective Inhibition of Methotrexate Excretion by Glucuronides of Nonsteroidal Anti-inflammatory Drugs via Multidrug Resistance Proteins 2 and 4. (Q53805550) (← links)
• The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits (Q68362187) (← links)
• The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon (Q68630599) (← links)
• Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits (Q69588120) (← links)
• Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid (Q69912783) (← links)
• Drug interactions (Q70692744) (← links)
• Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhoea (Q71156267) (← links)
• The effect of probenecid on paracetamol metabolism and pharmacokinetics (Q72361391) (← links)